Lim Wai H, McDonald Stephen P, Coates Patrick T, Chapman Jeremy R, Russ Graeme R, Wong Germaine
Department of Renal Medicine, Sir Charles Gairdner Hospital, Western Australia, Australia; Australia and New Zealand Dialysis and Transplant Registry, South Australia, Australia.
Australia and New Zealand Dialysis and Transplant Registry, South Australia, Australia; Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, South Australia, Australia; University of Adelaide, South Australia, Australia.
Kidney Int. 2016 Mar;89(3):659-65. doi: 10.1016/j.kint.2015.11.016. Epub 2016 Jan 6.
Noninherited maternal human leukocyte antigens may be less detrimental on allograft outcomes after kidney transplantation compared with noninherited paternal antigens, but this association in the era of modern immunosuppression remains unknown. Here we determine the association between parental donor kidneys, acute rejection, and graft failure in primary live-donor parental kidney transplant recipients using data from the Australia and New Zealand Dialysis and Transplant Registry between 1997 and 2012. Of the 1139 recipients followed for a median of 7.2 years (8588 person-years), 652 received kidneys from maternal donors. Compared with paternal donor kidneys, maternal donor kidneys were associated with a significantly increased risk of acute rejection (adjusted odds ratio 1.54; 95% confidence interval [CI], 1.14-2.07) and significant overall graft loss. The latter was confined to recipients who have experienced acute rejection (adjusted hazard ratio 1.60; 95%CI, 1.05-2.43) but not in those who did not experience acute rejection. Thus, our study suggests that recipients of maternal donor kidneys have a greater risk of rejection and graft loss. Hence, clinicians and patients should be cognizant of this association when determining which of the 2 parental donors is most suitable for transplantation.
与非遗传的父系人类白细胞抗原相比,非遗传的母系人类白细胞抗原对肾移植后同种异体移植结果的损害可能较小,但在现代免疫抑制时代,这种关联仍不清楚。在此,我们利用1997年至2012年澳大利亚和新西兰透析与移植登记处的数据,确定初次活体供体亲体肾移植受者中亲体供肾、急性排斥反应和移植失败之间的关联。在随访时间中位数为7.2年(8588人年)的1139名受者中,652名接受了来自母亲供体的肾脏。与父亲供肾相比,母亲供肾与急性排斥反应风险显著增加(调整后的优势比为1.54;95%置信区间[CI],1.14 - 2.07)以及显著的总体移植丢失相关。后者仅限于经历过急性排斥反应的受者(调整后的风险比为1.60;95%CI,1.05 - 2.43),而未经历急性排斥反应的受者则不然。因此,我们的研究表明,母亲供肾的受者发生排斥反应和移植丢失的风险更大。因此,临床医生和患者在确定两位亲体供体中哪一位最适合移植时应认识到这种关联。